Cargando…

A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma

BACKGROUND: Vestibular schwannoma (VS) is the most common benign tumor of the posterior fossa. The recurrence of VS has always received widespread attention. This study aimed to develop a nomogram to predict Recurrence-free survival (RFS) following resection of VS. METHODS: A total of 425 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zehan, Zhang, Ding, Shi, Xudong, Tao, Bingyan, Liu, Yuyang, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097914/
https://www.ncbi.nlm.nih.gov/pubmed/35574416
http://dx.doi.org/10.3389/fonc.2022.838112
_version_ 1784706268002254848
author Zhang, Zehan
Zhang, Ding
Shi, Xudong
Tao, Bingyan
Liu, Yuyang
Zhang, Jun
author_facet Zhang, Zehan
Zhang, Ding
Shi, Xudong
Tao, Bingyan
Liu, Yuyang
Zhang, Jun
author_sort Zhang, Zehan
collection PubMed
description BACKGROUND: Vestibular schwannoma (VS) is the most common benign tumor of the posterior fossa. The recurrence of VS has always received widespread attention. This study aimed to develop a nomogram to predict Recurrence-free survival (RFS) following resection of VS. METHODS: A total of 425 patients with VS who underwent resection at the Department of Neurosurgery in Chinese PLA General Hospital between January 2014 and December 2020 were enrolled in this retrospective study. The medical records and follow-up data were collected. Cox regression analysis was used to screen prognostic factors and construct the nomogram. The predictive accuracy and clinical benefits of the nomogram were validated using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). RESULTS: The Cox regression analysis revealed that age (HR = 0.96; 95% CI 0.94 - 0.99; p < 0.01), EOR (HR = 4.65; 95% CI 2.22 - 9.74; p < 0.001), and Ki-67 (HR = 1.16; 95% CI 1.09 - 1.23; p < 0.001) were all significantly correlated with recurrence, and they were finally included in the nomogram model. The concordance index of the nomogram was 0.86. The areas under the curve (AUCs) of the nomogram model of 3-, 4- and 5-year were 0.912, 0.865, and 0.809, respectively. A well-fitted calibration curve was also generated for the nomogram model. The DCA curves also indicated that the nomogram model had satisfactory clinical utility compared to the single indicators. CONCLUSIONS: We developed a nomogram that has high accuracy in predicting RFS in patients after resection of VS. All of the included prognostic factors are easy to obtain. The nomogram can improve the postoperative management of patients and assist clinicians in individualized clinical treatment. Furthermore, we generated a web-based calculator to facilitate clinical application: https://abc123-123.shinyapps.io/VS-RFS/.
format Online
Article
Text
id pubmed-9097914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90979142022-05-13 A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma Zhang, Zehan Zhang, Ding Shi, Xudong Tao, Bingyan Liu, Yuyang Zhang, Jun Front Oncol Oncology BACKGROUND: Vestibular schwannoma (VS) is the most common benign tumor of the posterior fossa. The recurrence of VS has always received widespread attention. This study aimed to develop a nomogram to predict Recurrence-free survival (RFS) following resection of VS. METHODS: A total of 425 patients with VS who underwent resection at the Department of Neurosurgery in Chinese PLA General Hospital between January 2014 and December 2020 were enrolled in this retrospective study. The medical records and follow-up data were collected. Cox regression analysis was used to screen prognostic factors and construct the nomogram. The predictive accuracy and clinical benefits of the nomogram were validated using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). RESULTS: The Cox regression analysis revealed that age (HR = 0.96; 95% CI 0.94 - 0.99; p < 0.01), EOR (HR = 4.65; 95% CI 2.22 - 9.74; p < 0.001), and Ki-67 (HR = 1.16; 95% CI 1.09 - 1.23; p < 0.001) were all significantly correlated with recurrence, and they were finally included in the nomogram model. The concordance index of the nomogram was 0.86. The areas under the curve (AUCs) of the nomogram model of 3-, 4- and 5-year were 0.912, 0.865, and 0.809, respectively. A well-fitted calibration curve was also generated for the nomogram model. The DCA curves also indicated that the nomogram model had satisfactory clinical utility compared to the single indicators. CONCLUSIONS: We developed a nomogram that has high accuracy in predicting RFS in patients after resection of VS. All of the included prognostic factors are easy to obtain. The nomogram can improve the postoperative management of patients and assist clinicians in individualized clinical treatment. Furthermore, we generated a web-based calculator to facilitate clinical application: https://abc123-123.shinyapps.io/VS-RFS/. Frontiers Media S.A. 2022-04-28 /pmc/articles/PMC9097914/ /pubmed/35574416 http://dx.doi.org/10.3389/fonc.2022.838112 Text en Copyright © 2022 Zhang, Zhang, Shi, Tao, Liu and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Zehan
Zhang, Ding
Shi, Xudong
Tao, Bingyan
Liu, Yuyang
Zhang, Jun
A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
title A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
title_full A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
title_fullStr A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
title_full_unstemmed A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
title_short A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
title_sort nomogram to predict recurrence-free survival following surgery for vestibular schwannoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097914/
https://www.ncbi.nlm.nih.gov/pubmed/35574416
http://dx.doi.org/10.3389/fonc.2022.838112
work_keys_str_mv AT zhangzehan anomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT zhangding anomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT shixudong anomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT taobingyan anomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT liuyuyang anomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT zhangjun anomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT zhangzehan nomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT zhangding nomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT shixudong nomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT taobingyan nomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT liuyuyang nomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma
AT zhangjun nomogramtopredictrecurrencefreesurvivalfollowingsurgeryforvestibularschwannoma